StockNews.com Downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) to Hold
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday. Separately, HC Wainwright reissued a “neutral” rating on shares of Oramed Pharmaceuticals in a report on Monday, September 9th. View Our […]
More Stories
Contrasting Seacoast Banking Co. of Florida (NASDAQ:SBCF) and John Marshall Bancorp (NASDAQ:JMSB)
John Marshall Bancorp (NASDAQ:JMSB – Get Free Report) and Seacoast Banking Co. of Florida (NASDAQ:SBCF – Get Free Report) are...
Spin Master Corp. (OTCMKTS:SNMSF) Announces $0.09 Dividend
Spin Master Corp. (OTCMKTS:SNMSF – Get Free Report) declared a dividend on Friday, December 20th,investing.com reports. Investors of record on...
Flexsteel Industries, Inc. (FLXS) To Go Ex-Dividend on December 27th
Flexsteel Industries, Inc. (NASDAQ:FLXS – Get Free Report) declared a quarterly dividend on Wednesday, December 11th,Wall Street Journal reports. Shareholders...
Canadian Imperial Bank of Commerce (CM) To Go Ex-Dividend on December 27th
Canadian Imperial Bank of Commerce (NYSE:CM – Get Free Report) (TSE:CM) announced a quarterly dividend on Friday, December 6th,Wall Street...
Sun Art Retail Group Limited (OTCMKTS:SURRY) Raises Dividend to $0.17 Per Share
Sun Art Retail Group Limited (OTCMKTS:SURRY – Get Free Report) declared a dividend on Wednesday, December 11th,NASDAQ Dividends reports. Investors...
Oklo (NYSE:OKLO) Shares Down 7.7% Following Insider Selling
Oklo Inc. (NYSE:OKLO – Get Free Report)’s stock price traded down 7.7% on Monday after an insider sold shares in...